date,title,source
Nov-01-18,"Magenta Therapeutics Announces Acceptance of Nine Abstracts Covering Clinical and Preclinical Data at ASH, Representing Progress across the Portfolio of Conditioning, Stem Cell Mobilization and Expansion Programs",Business Wire
Nov-08-18,Magenta Therapeutics Reports Recent Operational Progress and Third Quarter 2018 Financial Results,Business Wire
Nov-19-18,Magenta Therapeutics Appoints Jason Ryan as Chief Operating and Financial Officer,Business Wire
Nov-26-18,Magenta Therapeutics to Host Webcast of Investor and Analyst Event During ASH,Business Wire
Jan-02-19,"Magenta Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9, 2019",Business Wire
Feb-07-19,Magenta Therapeutics to Present at Guggenheim Healthcare Investor Conference,Business Wire
Feb-21-19,"Magenta Therapeutics Presents Preclinical Data on MGTA-145, First-Line Stem Cell Mobilization Product Candidate for Autologous and Allogeneic Bone Marrow Transplant",Business Wire
Feb-25-19,"Magenta Therapeutics Presents Preclinical Data on Targeted Non-Genotoxic Conditioning Programs, Including First Conditioning Development Candidate",Business Wire
Feb-25-19,Magenta Therapeutics Presents Clinical and Preclinical Data on MGTA-456 Cell Therapy in Best Abstracts Sessions at Transplant and Cellular Therapy (TCT) Annual Meeting,Business Wire
Mar-06-19,Magenta Therapeutics to Present at Investor Conferences in March,Business Wire
Mar-15-19,"How Many Insiders Bought Magenta Therapeutics, Inc. (NASDAQ:MGTA) Shares?",Simply Wall St.
Mar-19-19,Magenta Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Recent Business Highlights,Business Wire
Mar-20-19,Raymond James Thinks Magenta Still Has Upside,GuruFocus.com
Apr-24-19,"Magenta Therapeutics Announces First Subjects Dosed in Phase 1 Clinical Trial of MGTA-145, a First-Line Stem Cell Mobilization Product Candidate",Business Wire
Apr-29-19,Magenta Therapeutics Launches Proposed Public Offering,Business Wire
Apr-29-19,Magenta Therapeutics to Present Preclinical Data on E478 Stem Cell Gene Therapy Expansion Program at the 2019 Annual Meeting of the American Society of Gene and Cell Therapy,Business Wire
May-01-19,Magenta Therapeutics Announces Pricing of Public Offering,Business Wire
